9EWM
Mpro from SARS-CoV-2 with R4Q R298Q double mutations
Summary for 9EWM
Entry DOI | 10.2210/pdb9ewm/pdb |
Descriptor | Non-structural protein 11 (1 entity in total) |
Functional Keywords | sars-cov-2, protease, mpro, antiviral protein |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 1 |
Total formula weight | 33147.75 |
Authors | Plewka, J.,Lis, K.,Chykunova, Y.,Czarna, A.,Kantyka, T.,Pyrc, K. (deposition date: 2024-04-04, release date: 2024-04-24) |
Primary citation | Lis, K.,Plewka, J.,Menezes, F.,Bielecka, E.,Chykunova, Y.,Pustelny, K.,Niebling, S.,Garcia, A.S.,Garcia-Alai, M.,Popowicz, G.M.,Czarna, A.,Kantyka, T.,Pyrc, K. SARS-CoV-2 M pro oligomerization as a potential target for therapy. Int.J.Biol.Macromol., 267:131392-131392, 2024 Cited by PubMed: 38582483DOI: 10.1016/j.ijbiomac.2024.131392 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.63 Å) |
Structure validation
Download full validation report![Download](/newweb/media/icons/dl.png)
![Download](/newweb/media/icons/dl.png)